1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for RNXT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2022. Start Trial.
Date Value
September 21, 2026 25.56%
September 18, 2026 34.13%
September 17, 2026 41.80%
September 16, 2026 23.02%
September 15, 2026 35.43%
September 14, 2026 32.03%
September 11, 2026 41.94%
September 10, 2026 51.28%
September 09, 2026 71.98%
September 08, 2026 92.98%
September 04, 2026 100.8%
September 03, 2026 89.60%
September 02, 2026 133.3%
September 01, 2026 119.8%
August 31, 2026 101.0%
August 28, 2026 76.23%
August 27, 2026 60.07%
August 26, 2026 61.29%
August 25, 2026 58.06%
August 24, 2026 32.94%
August 21, 2026 47.75%
August 20, 2026 51.72%
August 19, 2026 42.72%
August 18, 2026 24.47%
August 17, 2026 25.59%
Date Value
August 14, 2026 12.90%
August 13, 2026 3.28%
August 12, 2026 1.82%
August 11, 2026 3.14%
August 10, 2026 1.75%
August 07, 2026 -6.67%
August 06, 2026 -4.17%
August 05, 2026 -13.11%
August 04, 2026 -14.05%
August 03, 2026 -12.40%
July 31, 2026 -22.72%
July 30, 2026 -21.57%
July 29, 2026 -26.39%
July 28, 2026 -27.42%
July 27, 2026 -24.01%
July 24, 2026 -33.44%
July 23, 2026 -32.72%
July 22, 2026 -32.38%
July 21, 2026 -31.97%
July 20, 2026 -33.56%
July 17, 2026 -33.44%
July 16, 2026 -32.23%
July 15, 2026 -34.88%
July 14, 2026 -39.29%
July 13, 2026 -28.92%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. 58.51%
Travere Therapeutics, Inc. 153.0%
REGENXBIO, Inc. -11.36%
Krystal Biotech, Inc. 104.1%
ACADIA Pharmaceuticals, Inc. 8.09%